Review




Structured Review

Angel Yeast Co Ltd β 1 3 1 6 glucan
β 1 3 1 6 Glucan, supplied by Angel Yeast Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm42103761-113-0-10?v=Angel+Yeast+Co+Ltd
Average 86 stars, based on 1 article reviews
β 1 3 1 6 glucan - by Bioz Stars, 2026-08
86/100 stars

Images



Similar Products

86
Angel Yeast Co Ltd β 1 3 1 6 glucan
β 1 3 1 6 Glucan, supplied by Angel Yeast Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm42103761-113-0-10?v=Angel+Yeast+Co+Ltd
Average 86 stars, based on 1 article reviews
β 1 3 1 6 glucan - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
ATCC 1 3 1 6
1 3 1 6, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm38243245-257-19-35?v=ATCC
Average 95 stars, based on 1 article reviews
1 3 1 6 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Mustafa Nevzat 1 → 3−1 → 6- β -d-glucan s. cerevisiae
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
1 → 3−1 → 6 β D Glucan S. Cerevisiae, supplied by Mustafa Nevzat, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pmc11208795-26-6-12?v=Mustafa+Nevzat
Average 90 stars, based on 1 article reviews
1 → 3−1 → 6- β -d-glucan s. cerevisiae - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Mustafa Nevzat 1 → 3−1 → 6- β -d-glucan
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the <t> glucan, </t> route of administration, treatment schedule, immunological activity, and references.
1 → 3−1 → 6 β D Glucan, supplied by Mustafa Nevzat, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pmc11208795-28-5-11?v=Mustafa+Nevzat
Average 90 stars, based on 1 article reviews
1 → 3−1 → 6- β -d-glucan - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Mustafa Nevzat microorganism—yeast —s. cerevisiae , 1 → 3−1 → 6- β -d-glucan
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
Microorganism—Yeast —S. Cerevisiae , 1 → 3−1 → 6 β D Glucan, supplied by Mustafa Nevzat, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pmc11208795-28-0-11?v=Mustafa+Nevzat
Average 90 stars, based on 1 article reviews
microorganism—yeast —s. cerevisiae , 1 → 3−1 → 6- β -d-glucan - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Kishida Chemical 1→3)-β-d-glucan branched by o-6 substitution
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
1→3) β D Glucan Branched By O 6 Substitution, supplied by Kishida Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm31887864-31-6-29?v=Kishida+Chemical
Average 90 stars, based on 1 article reviews
1→3)-β-d-glucan branched by o-6 substitution - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Leiber GmbH yeast (1 → 3)-(1→ 6)-β-d-glucan
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
Yeast (1 → 3) (1→ 6) β D Glucan, supplied by Leiber GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm31170489-31-4-14?v=Leiber+GmbH
Average 90 stars, based on 1 article reviews
yeast (1 → 3)-(1→ 6)-β-d-glucan - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Kulicke and Soffa Industries Inc β- (1→3, 1→6)-d-glucan (mw 2390 kda)
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
β (1→3, 1→6) D Glucan (Mw 2390 Kda), supplied by Kulicke and Soffa Industries Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm31320070-164-6-34?v=Kulicke+and+Soffa+Industries+Inc
Average 90 stars, based on 1 article reviews
β- (1→3, 1→6)-d-glucan (mw 2390 kda) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Biosynth Carbosynth β 1 6 side chains
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
β 1 6 Side Chains, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm30246424-201-10-28?v=Biosynth+Carbosynth
Average 90 stars, based on 1 article reviews
β 1 6 side chains - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Leiber GmbH insoluble (1/3)-(1/6)-β-glucan powder made from brewer’s yeast yestimun
Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.
Insoluble (1/3) (1/6) β Glucan Powder Made From Brewer’s Yeast Yestimun, supplied by Leiber GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%CE%B2+1+3+1+6+glucan/pm29705412-38-5-12?v=Leiber+GmbH
Average 90 stars, based on 1 article reviews
insoluble (1/3)-(1/6)-β-glucan powder made from brewer’s yeast yestimun - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.

Journal: Journal of Immunology Research

Article Title: Glucans: A Therapeutic Alternative for Sepsis Treatment

doi: 10.1155/2024/6876247

Figure Lengend Snippet: Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.

Article Snippet: Microorganism: yeast, S. cerevisiae , 1 → 3−1 → 6- β -D-Glucan (Mustafa Nevzat Company, Turkey. S. cerevisiae ) , In vivo ( rats: albino wistar ) , 50 mg (kg) , GIG , Once a day for 10 days , ↓ Zinc and copper levels of the liver, lung, kidney, heart, and diaphragm. ↓ Tissue damage , [ ] .

Techniques: Formulation, Activity Assay, Saline, In Vivo, Injection, Expressing, Translocation Assay, Mouse Assay, Activation Assay, In Vitro, Clinical Proteomics

Distribution of selected studies according to formulation, type of study, type and dose/concentration of the  glucan,  route of administration, treatment schedule, immunological activity, and references.

Journal: Journal of Immunology Research

Article Title: Glucans: A Therapeutic Alternative for Sepsis Treatment

doi: 10.1155/2024/6876247

Figure Lengend Snippet: Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.

Article Snippet: Microorganism—yeast —S. cerevisiae , 1 → 3−1 → 6- β -D-glucan (Mustafa Nevzat Company, Turkey. S. cerevisiae ) , In vivo ( rats: Wistar albino rats of both sexes ) , 50 mg (kg) , GIG , Once daily for 10 days and 30 min prior to and 6 hr after the CLP , ↓TNF- α ↓The MDA levels in the liver, kidney, heart, lung, diaphragm, and brain reversed the GSH level ↓ neutrophil infiltration , [ ] .

Techniques: Formulation, Activity Assay, Saline, In Vivo, Injection, Expressing, Translocation Assay, Mouse Assay, Activation Assay, In Vitro

Mechanism underlying the protective effects of glucan treatment in cecal ligation and puncture (CLP)-induced infections. Prophylactic and/or therapeutic treatment enables a better immune response from the host in the fight against infection. The mechanism involved in the response involves the modulation of the expression of genes related to mortality, such as TLR-4. The treatment made it possible to reduce the expression of these genes, as well as related proteins, correlating with improved long-term survival. In addition, it allows control of colony-forming units and facilitates a reduction in plasma levels of enzymes that actively participate in the inflammatory process, such as myeloperoxidase (MPO), which is strongly associated with neutrophil infiltration and subsequent tissue damage. The immune response stimulated through treatment with glucan protects the host, not only by increasing its survival rate but also by controlling exacerbated inflammatory response, preventing multiple organ dysfunction syndrome (MODS), highlighting the effectiveness of this natural product as a therapeutic intervention against serious infections.

Journal: Journal of Immunology Research

Article Title: Glucans: A Therapeutic Alternative for Sepsis Treatment

doi: 10.1155/2024/6876247

Figure Lengend Snippet: Mechanism underlying the protective effects of glucan treatment in cecal ligation and puncture (CLP)-induced infections. Prophylactic and/or therapeutic treatment enables a better immune response from the host in the fight against infection. The mechanism involved in the response involves the modulation of the expression of genes related to mortality, such as TLR-4. The treatment made it possible to reduce the expression of these genes, as well as related proteins, correlating with improved long-term survival. In addition, it allows control of colony-forming units and facilitates a reduction in plasma levels of enzymes that actively participate in the inflammatory process, such as myeloperoxidase (MPO), which is strongly associated with neutrophil infiltration and subsequent tissue damage. The immune response stimulated through treatment with glucan protects the host, not only by increasing its survival rate but also by controlling exacerbated inflammatory response, preventing multiple organ dysfunction syndrome (MODS), highlighting the effectiveness of this natural product as a therapeutic intervention against serious infections.

Article Snippet: Microorganism—yeast —S. cerevisiae , 1 → 3−1 → 6- β -D-glucan (Mustafa Nevzat Company, Turkey. S. cerevisiae ) , In vivo ( rats: Wistar albino rats of both sexes ) , 50 mg (kg) , GIG , Once daily for 10 days and 30 min prior to and 6 hr after the CLP , ↓TNF- α ↓The MDA levels in the liver, kidney, heart, lung, diaphragm, and brain reversed the GSH level ↓ neutrophil infiltration , [ ] .

Techniques: Ligation, Infection, Expressing, Control

Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.

Journal: Journal of Immunology Research

Article Title: Glucans: A Therapeutic Alternative for Sepsis Treatment

doi: 10.1155/2024/6876247

Figure Lengend Snippet: Distribution of selected studies according to formulation, type of study, type and dose/concentration of the glucan, route of administration, treatment schedule, immunological activity, and references.

Article Snippet: Microorganism—yeast —S. cerevisiae , 1 → 3−1 → 6- β -D-glucan (Mustafa Nevzat Company, Turkey. S. cerevisiae ) , In vivo ( rats: Wistar albino rats of both sexes ) , 50 mg (kg) , GIG , Once daily for 10 days and 30 min prior to and 6 hr after the CLP , ↓TNF- α ↓The MDA levels in the liver, kidney, heart, lung, diaphragm, and brain reversed the GSH level ↓ neutrophil infiltration , [ ] .

Techniques: Formulation, Activity Assay, Saline, In Vivo, Injection, Expressing, Translocation Assay, Mouse Assay, Activation Assay, In Vitro, Clinical Proteomics